ANNA MALOVANNAYA to DNA Helicases
This is a "connection" page, showing publications ANNA MALOVANNAYA has written about DNA Helicases.
Connection Strength
0.493
-
Superior preclinical efficacy of co-treatment with BRG1/BRM and FLT3 inhibitor against AML cells with FLT3 mutations. Blood Cancer J. 2025 03 15; 15(1):40.
Score: 0.205
-
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor. Blood. 2024 05 16; 143(20):2059-2072.
Score: 0.194
-
Inferring protein-protein interaction complexes from immunoprecipitation data. BMC Res Notes. 2013 Nov 15; 6:468.
Score: 0.094